In our study, both patients with T1DM and T2DM had more aggressive disease manifestation compared with patients with non-DM, including higher infection marker levels (CBC and CRP levels), more ICU admission, longer hospital stay, more acceptance of surgical debridement and tracheostomy, and more mediastinal complications. This evidence concerns the gene CRP and type 2 diabetes mellitus.